Aurora Cannabis (TSE:ACB) Stock Price Up 0.5% - What's Next?

Key Points

• Aurora Cannabis Inc.'s stock rose by 0.5%, trading at C$6.17 after previously closing at C$6.14, with a significant increase in trading volume of 61% compared to the average.
• The company has a market cap of C$337.55 million, a debt-to-equity ratio of 18.72, and a P/E ratio of -7.62, indicating financial challenges.
• Senior Officer Andre Jerome bought 8,000 shares at C$5.83 each, signaling insider confidence in the company's future performance.

Aurora Cannabis Inc. (TSE:ACB - Get Free Report)'s stock price was up 0.5% during mid-day trading on Friday . The stock traded as high as C$6.55 and last traded at C$6.17. Approximately 835,280 shares changed hands during mid-day trading, an increase of 61% from the average daily volume of 517,413 shares. The stock had previously closed at C$6.14.

Aurora Cannabis Stock Performance

The company has a market cap of C$315.12 million, a P/E ratio of -7.11 and a beta of 2.71. The firm has a 50 day moving average of C$6.63 and a 200-day moving average of C$6.70. The company has a quick ratio of 2.48, a current ratio of 3.42 and a debt-to-equity ratio of 18.72.

Insider Transactions at Aurora Cannabis

In other news, Senior Officer Andre Jerome acquired 8,000 shares of the company's stock in a transaction that occurred on Friday, June 20th. The shares were bought at an average price of C$5.83 per share, with a total value of C$46,640.00.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.